2015 Workshop: EUPATI Taking off in your Country

Workshop Presentations

Introduction to the breakout sessions & case studies presentations

Break-out group Presentations

Video of Speakers

Virtual SnapShots

Photos

Pre-workshop Evening	Conference
Social	Workshop

Review Articles

Patients involvement in medical R&D: Many views, varied ideas, one vision

With its kick-off event on 5th of September 2012, the European Patients' Academy on Therapeutic Innovation (EUPATI) provided an open ...
Read More

Report of the first EUPATI Workshop, Frankfurt, 5 September 2012

The European Patients’ Academy for Therapeutic Innovation (EUPATI) took its first steps towards the development of pan-European and national infrastructures ...
Read More

Your brand: communication and social media

Rob Camp kicked off this plenary session by declaring that he had been sending out tweets for the past couple ...
Read More

Why is patient education important now and tomorrow?

Why does EUPATI matter? The panel was formed by Róisín Adams from Ireland’s National Centre for Pharmacoeconomics, Simon Denegri, chair ...
Read More

And now what? Where to from here…

It was left to Nicola Bedlington from the European Patients’ Forum, Belgium, to reflect on the day’s discussion. Graham Love ...
Read More

National Networking Day

For most of the year, our EUPATI National Teams and Platforms (Networks) work tirelessly on patient involvement issues in their ...
Read More

Patient education taking off locally!

EUPATI has already established itself as a key player in the involvement of patients in medicines development in Europe. But ...
Read More

Patient experts sounding off in Dublin!

EUPATI’s vision for 2020 is of a society where patients are active “from A to Z”. The key outcomes will ...
Read More

National networks working! 3 case studies…

Before the workshop split into smaller break-out groups to look at specific aspects of developing the EUPATI presence at the ...
Read More

Patient education now and in the future throughout Europe!

“We had a very vibrant discussion,” said rapporteur Karin Holm, Patient Advocate for Cancer Research and Treatment (PARCT), Switzerland. The ...
Read More

Workshop Final Report